Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Pharmacology/Therapy

Use of ACE (angiotensin-converting enzyme) inhibitors and risk of lung cancer

Circulation: Cardiovascular Quality and Outcomes | Jan 17, 2021 Pharmacology/Therapy

The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients

Lung Cancer | Jan 14, 2021 Pharmacology/Therapy

Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC)

Lung Cancer | Jan 14, 2021 Pharmacology/Therapy

Appropriate number of adjuvant chemotherapy cycles for patients with stage 2 or 3 gastric cancer after curative gastrectomy: A multicenter cohort study

Annals of Surgical Oncology | Jan 13, 2021 Pharmacology/Therapy

Clinical experience with 75-mg dose of erlotinib for mutated metastatic EGFR non-small cell lung cancer

American Journal of Therapeutics | Jan 13, 2021 Pharmacology/Therapy

Frequency of and factors associated with nonmedical opioid use behavior among patients with cancer receiving opioids for cancer pain

JAMA | Jan 12, 2021 Pharmacology/Therapy

Osimertinib plus bevacizumab vs osimertinib in advanced lung cancer previously treated with EGFR-TKI

JAMA | Jan 12, 2021 Pharmacology/Therapy

Surgical and oncologic outcomes of hyperthermic intraperitoneal chemotherapy for uterine leiomyosarcoma: A systematic review of literature

Gynecologic Oncology | Jan 09, 2021 Pharmacology/Therapy

Effect of capecitabine maintenance therapy vs observation in early-stage triple-negative breast cancer

JAMA | Jan 08, 2021 Pharmacology/Therapy

Effect of corticosteroids on the outcome of patients with advanced non–small cell lung cancer treated with immune-checkpoint inhibitors

European Journal of Cancer | Jan 08, 2021 Pharmacology/Therapy

« Prev 1 … 53 54 55 56 57 … 375 Next »

Use of ACE (angiotensin-converting enzyme) inhibitors and risk of lung cancer

The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients

Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC)

Appropriate number of adjuvant chemotherapy cycles for patients with stage 2 or 3 gastric cancer after curative gastrectomy: A multicenter cohort study

Clinical experience with 75-mg dose of erlotinib for mutated metastatic EGFR non-small cell lung cancer

Frequency of and factors associated with nonmedical opioid use behavior among patients with cancer receiving opioids for cancer pain

Osimertinib plus bevacizumab vs osimertinib in advanced lung cancer previously treated with EGFR-TKI

Surgical and oncologic outcomes of hyperthermic intraperitoneal chemotherapy for uterine leiomyosarcoma: A systematic review of literature

Effect of capecitabine maintenance therapy vs observation in early-stage triple-negative breast cancer

Effect of corticosteroids on the outcome of patients with advanced non–small cell lung cancer treated with immune-checkpoint inhibitors

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

MD Clip on Pulmonary Hypertension Symptoms and Management with Dr Waseem

New research aims to transform treatments of aggressive blood cancer

Use of ACE (angiotensin-converting enzyme) inhibitors and risk of lung cancer

The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients

Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC)

Appropriate number of adjuvant chemotherapy cycles for patients with stage 2 or 3 gastric cancer after curative gastrectomy: A multicenter cohort study

Clinical experience with 75-mg dose of erlotinib for mutated metastatic EGFR non-small cell lung cancer

Frequency of and factors associated with nonmedical opioid use behavior among patients with cancer receiving opioids for cancer pain

Osimertinib plus bevacizumab vs osimertinib in advanced lung cancer previously treated with EGFR-TKI

Surgical and oncologic outcomes of hyperthermic intraperitoneal chemotherapy for uterine leiomyosarcoma: A systematic review of literature

Effect of capecitabine maintenance therapy vs observation in early-stage triple-negative breast cancer

Effect of corticosteroids on the outcome of patients with advanced non–small cell lung cancer treated with immune-checkpoint inhibitors

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article on Hypertension in CKD Patients: Management Updates

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

MD Clip on Pulmonary Hypertension Symptoms and Management with Dr Waseem

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic